Articles related to DRY EYE DISEASE (DED)

Discover how Miebo, supported by phase 3 clinical trials, offers a unique approach to dry eye disease by specifically targeting tear evaporation.

Learn how an integrative approach involving specialty lenses and pharmaceuticals can revolutionize treatment strategies for ocular and corneal conditions.

The study underscores the limitations of relying on single tests for diagnosing dry eye disease and advocates for a multi-test approach to enhance diagnostic accuracy. Explore how combining specific tests can significantly improve your diagnostic outcomes.

Look into the potential of using autologous serum eye drops to treat dry eyes. Despite marginal gains in symptoms and staining scores, the effectiveness overall is still unclear. Explore the study’s findings in greater detail to comprehend how dry eye treatment will develop.

As the optometry field advances, newer, more innovative medications are being introduced for the management of dry eye disease and Demodex blepharitis. These developments pave the way for more personalized and successful patient care.

Aldeyra’s reproxalap shows considerable promise as a breakthrough treatment for ocular surface inflammatory conditions, highlighting its potential in addressing a significant unmet need in the field of optometry. Explore these groundbreaking clinical trial results.